Today's Research Daily features new research reports on 16 major stocks, including Toyota Motor Corp. (TM), AstraZeneca PLC ...

AstraZeneca stock slumped Monday after its Daiichi Sankyo-partnered drug missed its mark in a study of patients with breast ...

Key Takeaways A breast cancer drug being developed by AstraZeneca failed to "achieve statistical significance" in helping ...

This surge came after the company announced approval to import and distribute Durvalumab (Imfinzi) infusion in two dosages.

Vandana Singh AstraZeneca's Asthma Drug Gets FDA Approval For Rare Disease Of Blood Vessel Inflammation The FDA has approved AstraZeneca's Fasenra for eosinophilic granulomatosis with polyangiitis ...

a gain of 26.7% for the S&P Composite 1500. AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A–F grades for each of five key investing factors: value, growth, momentum, ...

Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” second quarter 2024 ...

Pondy Oxides and Chemicals, Thangamayil Jewellery, Power Grid Corporation of India, Cubex Tubings, G R Infraprojects, Western ...

The AstraZeneca PLC ADR AZN slipped 1.58% to $77.14 Monday, on what proved to be an all-around great trading session for the ...

AstraZeneca Pharma India Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 16,870.25 Crore) operating in Pharmaceuticals sector. AstraZeneca Pharma India Ltd. key ...

On the ratings front, Erste Group upgraded AstraZeneca's stock from Hold to Buy, citing a robust financial structure and an above-average growth projection. TD Cowen and BofA Securities also ...

Stock falls as much as 5.6% in morning trade ... view on Dato TL01 FDA approval Sept 10 (Reuters) - London-listed AstraZeneca (AZN.L), opens new tab shares fell more than 5% on Tuesday after ...